CLGN
Collplant Biotechnologies LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.89M
P/E Ratio
—
EPS
$-1.04
Beta
0.64
52W High
$3.23
52W Low
$0.27
50-Day MA
$0.39
200-Day MA
$1.39
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
80.00
PEG Ratio
—
About Collplant Biotechnologies Ltd
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | 389,000 |
| Gross Profit (TTM) | -574,000 |
| EBITDA | $-12.07M |
| Operating Margin | -4267.00% |
| Return on Equity | -152.00% |
| Return on Assets | -61.30% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $0.34 |
| Price-to-Book | 1.00 |
| Price-to-Sales (TTM) | 12.57 |
| EV/Revenue | 8.46 |
| EV/EBITDA | -5.97 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -96.40% |
| Shares Outstanding | $14.42M |
| Float | $10.15M |
| % Insiders | 26.87% |
| % Institutions | 12.03% |
Historical Volatility
HV 10-Day
49.71%
HV 20-Day
56.03%
HV 30-Day
58.28%
HV 60-Day
110.28%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($11.12 target)
1
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026